Figure 3.
Figure 3. HPLC separation and mass spectrometric analysis of I540 and R572 peptides from the cell surface of aAPC/hTERT. (A) Primary structure of EGFP-hTERT is shown. (B) Expression of transduced EGFPTERT (open curve) was analyzed by flow cytometric analysis using the FL1 channel. Untransduced aAPCs were used as a control (filled curve). (C) Cell-surface peptides from aAPC/hTERT were acid stripped and separated by reverse-phase HPLC as described in “Materials and methods.” Peptide fractions were collected, subjected to mass spectral analysis, and fractions corresponding to those of synthetic I540 and R572 peptides were identified.

HPLC separation and mass spectrometric analysis of I540 and R572 peptides from the cell surface of aAPC/hTERT. (A) Primary structure of EGFP-hTERT is shown. (B) Expression of transduced EGFPTERT (open curve) was analyzed by flow cytometric analysis using the FL1 channel. Untransduced aAPCs were used as a control (filled curve). (C) Cell-surface peptides from aAPC/hTERT were acid stripped and separated by reverse-phase HPLC as described in “Materials and methods.” Peptide fractions were collected, subjected to mass spectral analysis, and fractions corresponding to those of synthetic I540 and R572 peptides were identified.

Close Modal

or Create an Account

Close Modal
Close Modal